Phoenix Life Sciences International Limited. (PLSI) 10-Q 2013 Q2 Quarterly report

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Irma N. Colón-Alonso, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)

the Quarterly Report on Form 10-Q of Mokita Ventures, Inc. for the period ended August 31, 2012 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Mokita Ventures, Inc.

Dated:  April 19, 2013

/s/ Irma N. Colón-Alonso

Irma N. Colón-Alonso

President, Chief Executive Officer,

Chief Financial Officer, Secretary,

Treasurer and Director

(Principal Executive Officer,

Principal Financial Officer and

Principal Accounting Officer)

Mokita Ventures, Inc.

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Mokita Ventures, Inc. and will be retained by Mokita Ventures, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.